GlassScriptPhysician profile
Benjamin Piantedosi
NPI 1205912144
$580.90
in general payments reported to CMS, 2019-2025
12 companies · $75.24 in 2025
The $75.24 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $76.32 · 2021: $121 · 2022: $57.92 · 2023: $44.79 · 2024: $34.64 · 2025: $75.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $111.66 | 2019-2023 | Jornay Pm |
| Tris Pharma INC | $88.41 | 2019-2022 | |
| Sanofi Pasteur INC. | $85.10 | 2020-2023 | |
| Glaxosmithkline, LLC. | $66.25 | 2019-2023 | Bexsero |
| Pfizer INC. | $59.53 | 2021-2025 | |
| Sobi, INC | $48.55 | 2019 | |
| Adlon Therapeutics L.P. | $29.22 | 2020-2021 | |
| Hologic Sales and Service, LLC | $22.63 | 2025 | Aptima |
| Sanofi-Aventis U.S. LLC | $21.70 | 2025 | |
| Cranial Technologies, INC | $20.73 | 2024 | Doc Band |
| Alk-Abello, INC | $14.12 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Piantedosi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.